SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000819050-20-000180
Filing Date
2020-08-12
Accepted
2020-08-12 16:15:50
Documents
57
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q bbi-20200630.htm   iXBRL 10-Q 1427128
2 EX-10.2 a2020063010qex102.htm EX-10.2 150797
3 EX-10.3 a2020063010qex103.htm EX-10.3 48885
4 EX-10.4 a2020063010qex104.htm EX-10.4 58816
5 EX-31.1 a2020063010qex311.htm EX-31.1 13220
6 EX-31.2 a2020063010qex312.htm EX-31.2 12799
7 EX-32.1 a2020063010qex321.htm EX-32.1 13995
  Complete submission text file 0000819050-20-000180.txt   5248325

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bbi-20200630.xsd EX-101.SCH 33893
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT bbi-20200630_cal.xml EX-101.CAL 54476
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT bbi-20200630_def.xml EX-101.DEF 160440
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT bbi-20200630_lab.xml EX-101.LAB 422930
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bbi-20200630_pre.xml EX-101.PRE 265387
13 EXTRACTED XBRL INSTANCE DOCUMENT bbi-20200630_htm.xml XML 640109
Mailing Address 5777 CENTRAL AVENUE SUITE 102 BOULDER CO 80301
Business Address 5777 CENTRAL AVENUE SUITE 102 BOULDER CO 80301 (720) 505-4755
Brickell Biotech, Inc. (Filer) CIK: 0000819050 (see all company filings)

IRS No.: 930948554 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-21088 | Film No.: 201095656
SIC: 2836 Biological Products, (No Diagnostic Substances)